Information Sheet

This information sheet explains terms, definitions, and methods of calculation used in HIV surveillance data, and the uses of these data. It defines unadjusted data, adjusted (estimated) data, AIDS diagnoses and deaths of persons with an AIDS diagnoses, and diagnoses of HIV infection and deaths of persons with a diagnosis of HIV infection. It also defines HIV incidence, persons living with a diagnosis of HIV infection or AIDS, incidence rate, prevalence rate, stage of disease, and transmission category.

This fact sheet presents basic facts about TB. It explains the difference between latent TB infection (LTBI) and TB disease, TB transmission, symptoms of TB disease, skin testing procedures, the TB blood test, the chest X-ray, and the sputum test. The information sheet also discusses the medical treatments available for TB, including preventive treatment for persons with LTBI. It emphasizes the importance of finishing all TB medicine and taking the drugs exactly as prescribed to prevent the TB germs from reappearing and becoming resistant to the drugs.

This fact sheet discusses TB and how it is affected by the HIV. It defines TB and explains the difference between TB infection and latent TB infection. The fact sheet advises that HIV weakens the immune system increasing the chance that in people with HIV and latent TB, the TB germs will become active and attack the body causing TB disease. It emphasizes the importance of TB treatment and taking the TB drugs as prescribed.

Using a question and answer format, this fact sheet provides general information on TB prevention. It discusses TB transmission, infection, disease, diagnosis through a skin test or a special TB blood test, and treatment. It explains that TB is spread by germs that are in the air after someone with TB disease sneezes, coughs, speaks, laughs, or sings. TB germs can live in the body without making the individual sick. This is called latent TB infection. If the germs become active, they cause TB disease. An individual who has been exposed to TB germs will be given a TB skin test.

This information sheet discusses infection control measures for health care settings to ensure prompt detection, take airborne precautions, and treat persons with suspected or diagnosed tuberculosis infection. It suggests that policies and procedures for TB control should be developed, reviewed periodically, and evaluated to minimize transmission risk.

This information sheet discusses TB and the risk for international travelers. It explains TB transmission, multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of the disease, and how drug resistance occurs. The information sheet considers whether international travelers are at risk of MDR or XDR TB while traveling, the risk of acquiring TB on an airplane, how TB can be prevented, TB vaccine, and what an individual should do before traveling internationally and if an individual thinks that he/she may have been exposed to someone with TB disease.

This information sheet discusses TB and the risk for international travelers. It explains TB transmission, multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of the disease, and how drug resistance occurs. The information sheet considers whether international travelers are at risk of MDR or XDR TB while traveling, the risk of acquiring TB on an airplane, how TB can be prevented, TB vaccine, and what an individual should do before traveling internationally and if an individual thinks that he/she may have been exposed to someone with TB disease.

This information sheet explains TB for employers in non-healthcare settings. It describes TB disease, latent TB infection (LTBI), active TB, how it is determined whether a patient has active TB or LTBI, the symptoms of TB, what one should do if an employee reports having positive TB or has been in contact with someone with TB, and what happens after the employer contacts the local or state TB program.